Breast Cancer

Breast Cancer Patients See Improved QoL With Yoga

News | March 06, 2014 | Breast Cancer

Besides easing fatigue, yoga also eases pain and depression for women with breast cancer undergoing radiation therapy, a new study finds.

A Step Toward Personalized Care in Advanced Breast Cancer

Anna Azvolinsky, PhD

News | February 27, 2014 | Breast Cancer

By Anna Azvolinsky, PhD

Researchers have reported the results of the first large-scale, whole-genome study of advanced breast cancer. The analysis of the sequences has resulted in identification of a subset of patients who have a higher chance of benefiting from specific personalized therapy.

New Breast Cancer Surgical Guidelines Published

Anna Azvolinsky, PhD

News | February 21, 2014 | Breast Cancer

By Anna Azvolinsky, PhD

SSO and ASTRO have released a new set of consensus guidelines that could reduce healthcare costs and improve treatment for women with breast cancer.

Investigational Agent May Promote Metastasis in Triple-Negative Breast Cancer

Anna Azvolinsky, PhD

News | February 16, 2014 | Triple-Negative Breast Cancer, Breast Cancer

By Anna Azvolinsky, PhD

A new study shows that in some cases, inhibiting the growth of primary tumors can promote the spread of tumor cells to other parts of the body.

ACR Appropriateness Criteria® Local-Regional Recurrence (LRR) and Salvage Surgery—Breast Cancer

Michele Y. Halyard, MD

Eleanor E. R. Harris, MD

Lisa Bailey, MD

Review Article | February 15, 2014 | Oncology Journal, Breast Cancer, Radiation Oncology

By Michele Y. Halyard, MD, Eleanor E. R. Harris, MD, Lisa Bailey, MD, Jennifer R. Bellon, MD, Gary M. Freedman, MD, Sharad Goyal, MD, Kathleen C. Horst, MD, Meena S. Moran, MD, Catherine C. Park, MD, W. Warren Suh, MD, Deborah Toppmeyer, MD, and Bruce G. Haffty, MD

Management recommendations for breast cancer local-regional recurrence (LRR), including patient scenarios, are reviewed, and represent evidence-based data and expert opinion of the American College of Radiology Appropriateness Criteria Expert Panel on LRR.

Smoking Increases Risk of ER-Positive Breast Cancer

Anna Azvolinsky, PhD

News | February 13, 2014 | Breast Cancer, Triple-Negative Breast Cancer

By Anna Azvolinsky, PhD

A new study found that smoking increases the risk of estrogen receptor (ER)-positive breast cancer for young women.

Engineered Virus in Triple-Negative Breast Cancer Shows Treatment Potential

Leah Lawrence

News | February 10, 2014 | Triple-Negative Breast Cancer, Breast Cancer

By Leah Lawrence

Scientists have discovered that the injection of an engineered virus into triple-negative breast cancer cells may allow the cancers to be treated with therapeutic radioiodine, a treatment traditionally used to treat thyroid cancers.

Pages

Videos
Podcasts

Nine of Ten Women Cannot Quantify Lifetime Breast Cancer Risk
Leah Lawrence
News | September 10, 2013 | ASCO 2013 Breast Cancer Symposium, Breast Cancer
By Leah Lawrence
More than 90% of women about to undergo a mammography were unable to accurately quantify their risk for breast cancer, either over- or underestimating their risk, according to the results of a large-scale survey presented at the ASCO Breast Cancer Symposium 2013.
Batch MRI Breast Cancer Screening Possibility With Accelerated Protocol
Leah Lawrence
News | September 09, 2013 | ASCO 2013 Breast Cancer Symposium, Breast Cancer, Screening
By Leah Lawrence
Expert radiologists were able to screen magnetic resonance images and rule out breast cancer diagnosis with a negative predictive value of about 99% using an abridged breast MRI protocol in a single-center study presented Saturday at the ASCO Breast Cancer Symposium 2013.
What to Look for at This Year’s ASCO Breast Cancer Symposium
Tari A. King, MD
September 14, 2012 | ASCO 2012 Breast Cancer Symposium, Breast Cancer
By Tari A. King, MD
In this video, Tari A. King, MD, of the Memorial Sloan-Kettering Cancer Center, discusses what to look for at this year’s ASCO Breast Cancer Symposium.
ASCO: New Research on HER2-Positive Breast Cancer
Luca Gianni, MD
June 13, 2011 | ASCO 2011 Breast Cancer, Breast Cancer, ASCO 2011, HER2-Positive Breast Cancer, Triple-Negative Breast Cancer
By Luca Gianni, MD
Dr. Gianni has been involved with new drug therapies in medical oncology for some time, and in this interview he discusses the changing use of breast cancer treatments, neoadjuvant regimens, and research and developments on HER2+ breast cancer.

Circling Back: Duration of Adjuvant Endocrine Therapy for Breast Cancer
Nancy E. Davidson, MD
Rachel C. Jankowitz, MD
January 16, 2014 | Oncology Journal, Breast Cancer
By Nancy E. Davidson, MD and Rachel C. Jankowitz, MD
In this Circling Back feature, authors of the review article “Adjuvant Endocrine Therapy for Breast Cancer: How Long Is Long Enough?” discuss some of the especially interesting points made in the commentaries.
Sentinel Lymph Node Surgery for Breast Cancer
Kelly K. Hunt, MD
October 25, 2013 | Breast Cancer
By Kelly K. Hunt, MD
A recent prospective trial showed sentinel lymph node surgery has a clinically significant high false negative rate in breast cancer patients with node-positive disease receiving neoadjuvant chemotherapy. In this interview we discuss surgical techniques that detect breast cancer in lymph nodes.
Identifying Indolent vs Potentially Aggressive DCIS, More Research Needed
Susan K. Boolbol, MD
Conference Report | September 07, 2013 | ASCO 2013 Breast Cancer Symposium, Breast Cancer
By Susan K. Boolbol, MD
As part of our coverage for the ASCO Breast Cancer Symposium 2013, we spoke with Dr. Susan K. Boolbol, chief of the division of breast surgery at the Appel-Venet Comprehensive Breast Service at Beth Israel Medical Center in New York City, who is chairing a general session panel discussion on the overdiagnosis of breast cancer.
ASCO: Neoadjuvant Therapy Options and Clinical Trials in Breast Cancer
Angela DeMichele, MD
May 29, 2013 | Breast Cancer, ASCO 2013 Breast Cancer
By Angela DeMichele, MD
Ahead of the ASCO 2013 meeting we discuss neoadjuvant therapy options and clinical trials in breast cancer, as well as the opportunities for targeted therapies in post-neoadjuvant trials.

Breast Cancer

Topics

Breast Cancer

Pages

Oncology Current Issue

SearchMedica Rx

Register Today — It's Free!

UBM Medica Network

About UBM Medica

Breast Cancer

Topics

Breast Cancer

Pages

Already Registered? Login Now:

Register Today - It's Free!

Oncology Current Issue

SearchMedica Rx

Register Today — It's Free!

UBM Medica Network

About UBM Medica

Find Us On...